The impact of a titania (TiO2) support film surface on the catalytic activity of gold nanoparticles (Au NP) was investigated. Using the reactive dc-magnetron sputtering technique, TiO2 films with an amorphous, anatase, and nitrogen-doped anatase crystal structure were produced for a subsequent role as a support material for Au NP. Raman spectra of these TiO2 films revealed that both vacuum and NH3 annealing treatments promoted amorphous to anatase phase transformation through the presence of a peak in the 513–519 cm−1 spectral regime. Furthermore, annealing under NH3 flux had an associated blue shift and broadening of the Raman active mode at 1430 cm−1, characteristic of an increase in the oxygen vacancies (VO). For a 3 to 15 s sputter deposition time, the Au NP over TiO2 support films were in the 6.7–17.1 nm size range. From X-ray photoelectron spectroscope (XPS) analysis, the absence of any shift in the Au 4f core level peak implied that there was no change in the electronic properties of Au NP. On the other hand, spontaneous hydroxyl (–OH) group adsorption to anatase TiO2 support was instantly detected, the magnitude of which was found to be enhanced upon increasing the Au NP loading. Nitrogen-doped anatase TiO2 supporting Au NP with ~21.8 nm exhibited a greater extent of molecular oxygen adsorption. The adsorption of both –OH and O2 species is believed to take place at the perimeter sites of the Au NP interfacing with the TiO2 film. XPS analyses and discussions about the tentative roles of O2 and –OH adsorbent species toward Au/TiO2 systems corroborate very well with interpretations of density functional theory simulations.

BackgroundTo determine the incidence of congenital hypothyroidism (CH) with a delayed increase in thyroid-stimulating hormone (TSH) levels in preterm infants and to describe the associated factors.MethodsA prospective newborn screening (NBS) was conducted in 122 very low birth weight (VLBW) premature neonates born between June 2016 and September 2017. A dried blood spot thyroid stimulating hormone (TSH) level ≥15 mIU/L at 7 and 15 days of life, ≥10 in serum at the second screen or ≥5 at the third screen was defined as positive for CH. A concomitant increase in the TSH level and normal free thyroxine (T4) level was classified as hyperthyrotropinemia (HT).ResultsBefore the first month of life, no cases of CH were identified. However, the second and third NBS identified 10 and six subjects with HT, respectively, but no cases of CH. The overall cumulative incidence of HT was 1:8. Small for gestational age (SGA) was a variable that was significantly associated with HT, even after the exclusion of patients with Down syndrome.ConclusionsA high incidence of HT, but not CH, was found after the first month of life in preterm infants. Being SGA was strongly associated with having higher TSH. The need for repeating TSH screening after the first month of life in this population remains to be established.

Letters to the Editor age. The potential triggers for TE are an acute illness with fever, systemic diseases, severe emotional stress, major surgery, rapid weight loss, nutritional deficiency, endocrine disorders and drug exposure. Acute TE occurs within 2-3 months after the triggering event and usually resolves itself on its own or if the trigger is eliminated. 2 Hair loss due to TE has been reported in adult patients following COVID-19 infection, 3 and only 1 pediatric patient with MIS-C. 4 This case highlights that hair loss may occur as a late complication of MIS-C. Future studies are needed to define the long-term complications of MIS-C.